213 related articles for article (PubMed ID: 37644431)
21. Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFR.
Vaidya KS; Mitten MJ; Zelaya-Lazo AL; Oleksijew A; Alvey C; Falls HD; Mishra S; Palma J; Ansell P; Phillips AC; Reilly EB; Anderson M; Boghaert ER
J Neurooncol; 2021 Apr; 152(2):233-243. PubMed ID: 33517558
[TBL] [Abstract][Full Text] [Related]
22. Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts.
Hodgson JG; Yeh RF; Ray A; Wang NJ; Smirnov I; Yu M; Hariono S; Silber J; Feiler HS; Gray JW; Spellman PT; Vandenberg SR; Berger MS; James CD
Neuro Oncol; 2009 Oct; 11(5):477-87. PubMed ID: 19139420
[TBL] [Abstract][Full Text] [Related]
23. Uniform MDM2 overexpression in a panel of glioblastoma multiforme cell lines with divergent EGFR and p53 expression status.
Halatsch ME; Schmidt U; Unterberg A; Vougioukas VI
Anticancer Res; 2006; 26(6B):4191-4. PubMed ID: 17201132
[TBL] [Abstract][Full Text] [Related]
24. Foretinib induces G2/M cell cycle arrest, apoptosis, and invasion in human glioblastoma cells through c-MET inhibition.
Gortany NK; Panahi G; Ghafari H; Shekari M; Ghazi-Khansari M
Cancer Chemother Pharmacol; 2021 Jun; 87(6):827-842. PubMed ID: 33688998
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of hTERT and concurrent treatment with interferon-gamma inhibited proliferation and invasion of human glioblastoma cell lines.
George J; Banik NL; Ray SK
Int J Biochem Cell Biol; 2010 Jul; 42(7):1164-73. PubMed ID: 20394835
[TBL] [Abstract][Full Text] [Related]
26. Knock down of p53 levels in human keratinocytes increases susceptibility to type I and type II interferon-induced apoptosis mediated by a TRAIL dependent pathway.
Chaturvedi V; Bodner B; Qin JZ; Nickoloff BJ
J Dermatol Sci; 2006 Jan; 41(1):31-41. PubMed ID: 16289694
[TBL] [Abstract][Full Text] [Related]
27. Psoralen with ultraviolet A-induced apoptosis of cutaneous lymphoma cell lines is augmented by type I interferons via the JAK1-STAT1 pathway.
Liszewski W; Naym DG; Biskup E; Gniadecki R
Photodermatol Photoimmunol Photomed; 2017 May; 33(3):164-171. PubMed ID: 28196286
[TBL] [Abstract][Full Text] [Related]
28. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
Arif T; Krelin Y; Shoshan-Barmatz V
Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
[TBL] [Abstract][Full Text] [Related]
29. Analysis of gene expression in hepatitis B virus transfected cell line induced by interferon.
Xiong W; Wang X; Liu XY; Xiang L; Zheng LJ; Liu JX; Yuan ZH
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Dec; 35(12):1053-60. PubMed ID: 14673494
[TBL] [Abstract][Full Text] [Related]
30. Interferon-alpha2b induces p21cip1/waf1 degradation and cell proliferation in HeLa cells.
Ota K; Matsumiya T; Sakuraba H; Imaizumi T; Yoshida H; Kawaguchi S; Fukuda S; Satoh K
Cell Cycle; 2010 Jan; 9(1):131-9. PubMed ID: 20016288
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition.
Dixit D; Sharma V; Ghosh S; Mehta VS; Sen E
Cell Death Dis; 2012 Feb; 3(2):e271. PubMed ID: 22318540
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic implications of interferon regulatory factor (IRF)-1 and IRF-2 in diffusely infiltrating astrocytomas (DIA): response to interferon (IFN)-beta in glioblastoma cells and prognostic value for DIA.
Yoshino A; Katayama Y; Yokoyama T; Watanabe T; Ogino A; Ota T; Komine C; Fukushima T; Kusama K
J Neurooncol; 2005 Sep; 74(3):249-60. PubMed ID: 16187022
[TBL] [Abstract][Full Text] [Related]
33. Dual targeting of Polo-like kinase 1 and baculoviral inhibitor of apoptosis repeat-containing 5 in TP53-mutated hepatocellular carcinoma.
Li Y; Zhao ZG; Luo Y; Cui H; Wang HY; Jia YF; Gao YT
World J Gastroenterol; 2020 Aug; 26(32):4786-4801. PubMed ID: 32921957
[TBL] [Abstract][Full Text] [Related]
34. Synergistic Effects of Taurine and Temozolomide Via Cell Proliferation Inhibition and Apoptotic Induction on U-251 MG Human Glioblastoma Cells.
Surarak T; Chantree P; Sangpairoj K
Asian Pac J Cancer Prev; 2021 Dec; 22(12):4001-4009. PubMed ID: 34967582
[TBL] [Abstract][Full Text] [Related]
35. Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.
Lee C; Fotovati A; Triscott J; Chen J; Venugopal C; Singhal A; Dunham C; Kerr JM; Verreault M; Yip S; Wakimoto H; Jones C; Jayanthan A; Narendran A; Singh SK; Dunn SE
Stem Cells; 2012 Jun; 30(6):1064-75. PubMed ID: 22415968
[TBL] [Abstract][Full Text] [Related]
36. Tangeretin induces cell cycle arrest and apoptosis through upregulation of PTEN expression in glioma cells.
Ma LL; Wang DW; Yu XD; Zhou YL
Biomed Pharmacother; 2016 Jul; 81():491-496. PubMed ID: 27261630
[TBL] [Abstract][Full Text] [Related]
37. P53 status, and G2/M cell cycle arrest, are determining factors in cell-death induction mediated by ELF-EMF in glioblastoma.
Mehdizadeh R; Madjid Ansari A; Forouzesh F; Shahriari F; Shariatpanahi SP; Salaritabar A; Javidi MA
Sci Rep; 2023 Jul; 13(1):10845. PubMed ID: 37407632
[TBL] [Abstract][Full Text] [Related]
38. Silencing of ZFP36L2 increases sensitivity to temozolomide through G2/M cell cycle arrest and BAX mediated apoptosis in GBM cells.
Che Mat MF; Mohamad Hanif EA; Abdul Murad NA; Ibrahim K; Harun R; Jamal R
Mol Biol Rep; 2021 Feb; 48(2):1493-1503. PubMed ID: 33590411
[TBL] [Abstract][Full Text] [Related]
39. Induction of survivin inhibition, G₂/M cell cycle arrest and autophagic on cell death in human malignant glioblastoma cells.
Tang TK; Chiu SC; Lin CW; Su MJ; Liao MH
Chin J Physiol; 2015 Apr; 58(2):95-103. PubMed ID: 25858470
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of IFN-gamma and acyclovir on the glioblastoma cell cycle.
Kominsky SL; Subramaniam PS; Johnson HM; Torres BA
J Interferon Cytokine Res; 2000 May; 20(5):463-9. PubMed ID: 10841074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
